Tradestie Institutional Equity Comparison Engine
CISS vs GCTK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CISS Overall Edge
CISS Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to C3is Inc. Common Stock (CISS) driven by superior Growth & Margin, Momentum & Technical while GCTK counters with relative strength in Options & Structure. Fundamentally, CISS trades at N/M Forward P/E with 24.6% operating margin (+249.0% YoY revenue) versus GCTK at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CISS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against GCTK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CISS N/M vs GCTK N/M Fwd P/E
Growth & Margin Winner
CISS
Op Margin 24.6% vs 0.0% ยท YoY +249.0% vs +0.0%
Momentum & Technical Winner
CISS
1Y -25.4% vs -81.0% ยท 52W Pos 20% vs 16%
Options & Structure Winner
GCTK
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
CISS
NASDAQ
C3is Inc. Common Stock
Deep Sea Foreign Transportation Of Freight
$1.23
+4.24% 1D
Market Cap
$991,199
1M Return
+135.23%
1Y Return
-25.45%
Forward P/E
N/M
Unified AI Score
33.6 / 100
SELL
Tech 5.0
Fund 29.0
Flow 50.0
Mom 40.0
GCTK
NASDAQ
GlucoTrack, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.39
-32.2% 1D
Market Cap
$2.4M
1M Return
-15.24%
1Y Return
-80.96%
Forward P/E
N/M
Unified AI Score
36.9 / 100
SELL
Tech 5.0
Fund 40.0
Flow 50.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CISS -25.45%
GCTK -80.96%
Spread: +5.26 pp (CISS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CISS Revenue | GCTK Revenue | CISS Op. Margin | GCTK Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2015 | N/A | $0M | N/A | -3251.7% | GCTK |
| FY2016 | N/A | $0M | N/A | -924.6% | GCTK |
| FY2017 | N/A | $0M | N/A | 1794.2% | GCTK |
| FY2018 | N/A | $0M | N/A | -15035.4% | GCTK |
| FY2019 | N/A | $0M | N/A | 1685.6% | GCTK |
| FY2023 | $30M | N/A | 36.3% | N/A | CISS |
| FY2024 | $40M | N/A | 23.8% | N/A | CISS |
| FY2025 | $30M | N/A | 3.9% | N/A | CISS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CISS | GCTK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $991,199 | $2.4M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +249.0% | +0.0% | Higher Growth | CISS |
| Operating Margin (TTM) Profitability | 24.6% | 0.0% | Higher Margin | CISS |
| Net Profit Margin Profitability | 27.4% | 0.0% | Higher Margin | CISS |
| Return on Equity (ROE) Capital Efficiency | 17.1% | -620.6% | Higher ROE | CISS |
| 52-Week Range Position Momentum | 20% ($0โ$6) | 16% ($0โ$8) | Stronger Trend | CISS |
| Beta / 30D Volatility Risk Regime | 11.91ฮฒ ยท 1054% Vol | 1.08ฮฒ ยท 1052% Vol | Lower Realized Risk | GCTK |
| Unified Institutional Score Composite Signal | 33.6 / 100 (SELL) | 36.9 / 100 (SELL) | Higher Composite | GCTK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CISS vs GCTK Buy Guide
CISS
BREAKDOWN
64d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GCTK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CISS nor GCTK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.